Activated RAS continuously activates a series of downstream signaling pathways, including mitogen-activated protein kinase (MAPK) pathway (RAS/RAF/MEK/ERK) (McCubrey et al., 2007; Mendoza et al., 2011), which is a promising therapeutic target in cancer (Braicu et al., 2019). The gene discussed is MAP2K7; the disease is cancer.